InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Wu Yifang, Executive. Insider active across 1 company, notably Everest Medicines Ltd.. Cumulatively, 7 disclosures have been recorded. Activity tracked since 27 March 2026. The latest transaction was filed on 4 June 2026 (Purchase). Regulator: HKEX. The full history is accessible without signup.
7 of 7 declarations
Wu Yifang is an executive at Everest Medicines Ltd. He is involved in managing the operations and strategy of the company in the pharmaceutical sector. Wu Yifang collaborates with the management team to develop innovative solutions and meet market needs. His role is essential in ensuring the growth and competitiveness of Everest Medicines.